BioPharma Services Receives 2022 Biotechnology Award from GHP

TORONTO, ON, April 29, 2022 – Slated for being a Leading Provider of Pharma Product of Clinical Trial Services in 2022, BioPharma Services Inc. is happy to announce its acceptance of the Biotechnology Award for this year. Presented by Global Health & Pharma Magazine (GHP) News, a leading provider with a goal to support and help showcase the latest developments, most promising innovations and leading companies across the medical and health industries. BioPharma Services has had the opportunity to be featured in their seventh annual Biotechnology Awards.

“The Biotechnology Awards will once again cast a shining light on the pioneers and leading innovators within this crucial and ever-evolving sector. The year of 2021 posed many threats to the health and wellbeing of millions worldwide, and with thanks to the developments and perseverance of the global biotechnology landscape, millions are able to live full and healthy lives.“

GHP sits down with Jo Ann Di Sensi, Vice President and Global Quality and Privacy Officer at BioPharma Services. In their interview, they discuss the many successes at BioPharma Services, stemming not only from great leadership, but from the dedicated team being their driving force. The latest digitization efforts in collaboration with Think Research, the parent company of BioPharma Services, is transforming and future proofing the company. While this year is far from over, there are huge plans in the works not only to improve domestically, but influence the rest of the industry.

Click Here to read the full article.